Scientific Program |
|
Thursday, 6th September 2007 |
| 13:00 | Introduction Daniel Pauleikhoff (Münster, Germany) Welcome address on behalf of the German Ophthalmological Society (DOG) Frank G. Holz (Bonn, Germany) |
||||
13:10 15:16 |
1st Session: Epidemiology, Risk Factors and Genetics
|
||||
| 1 L | Hugh H.Taylor (Melbourne, Australia) AMD - burden of illness in the western world |
||||
| 2 R | Ronald Klein, S. Meuer, M. Knudtson (Madison, USA) Epidemiology of reticular drusen |
||||
| 3 L | BurAstrid Meister, Astrid Meister, M. Dietzel, D. Pauleikhoff, H.-W. Hense (Münster, Germany) Risk factors for AMD in the MARS-Study |
||||
| 4 P | Hendrik P. N. Scholl (Bonn, Germany) Complement factor H and LOC387715 gene polymorphisms and their correlation with risk and progression of AMD |
||||
| 5 L | Eric Souied (Créteil, France) Sibling Study on Age-Related Maculopathy |
||||
| 6 L | Hans-Werner Hense, A. Farwick, M. Stoll, D. Pauleikhoff (Münster, Germany) Genetic analysis in epidemiological studies - experience of the MARS-study |
||||
| 7 P | Carel B. Hoyng, C. Boon, B.J. Klevering, F. Cremers, A. den Hollander (Nijmegen, Netherlands) Genetic findings in early-onset drusen maculopathy |
||||
| 8 P | Victor Chong, E. Fletcher, T. Adewoyin, V. Calder (London, Great Britain) Biomarkers for age-related macular degeneration |
||||
| 9 P | Temi Adewoyin, E. Fletcher, V. Calder, V. Chong (London, Great Britain) Matrix protein profiling in patients with age-related macular degeneration |
||||
| 10 P | Emily Fletcher, T. Adewoyin, V. Calder, V. Chong (London, Great Britain) Cytokine profiling in patients with age-related macular degeneration |
||||
| 11 L | Andrew Webster (London, Great Britain) Genotyp-phenotyp correlation in AMD |
||||
| 12 L | Alan C. Bird (London, Great Britain) Perspectives of AMD genetics: How to proceed, what to expect? |
||||
| 16:00 16:30 |
Coffee break in the industrial exhibition area | ||||
| 16:30 18:00 |
2nd Session: Pathogenetic Concepts
|
||||
| 13 L | Peter F. Zipfel (Jena, Germany) Role of complement factor H in health and disease |
||||
| 14 L | Philip J. Luthert (London, Great Britain) Phenotypic analysis of aged mice with complement factor H gene deletion - a multidisciplinary approach |
||||
| 15 L | Gregory S. Hageman (Iowa City, USA)) Aberrant complement activation and regulation in age-related macular degeneration |
||||
| 16 P | Susanne Wasmuth, M. Hennig, M. Trieschmann, G. Spital, A. Lommatzsch, D. Pauleikhoff (Münster, Germany) Biological reactions of retinal pigment epithelial cells on complement challenge in vitro |
||||
| 17 P | Peter Charbel Issa, S. Janzer, F. Börnke, L. Fritsche, T. Wienker, B.H.F. Weber, M. Oppermann, H.P.N. Scholl, F.G. Holz (Bonn, Germany) Signs of systemic complement activation in patients with age-related macular degeneration |
||||
| 18 P | Bettine Polak, P. Ringens, J. Worst (Amsterdam, Netherlands) Physiological vitreous changes may contribute to the pathogenesis of atrophic and neovascular AMD |
||||
| 19 L | Dean Bok (Los Angeles, USA) Perspectives on AMD pathogenesis: How to proceed, what to expect |
||||
| 18:00 | Drinks and get together in the industrial exhibition / Kongresshaus |